LOCALIZATION OF NEUROPEPTIDE-Y AND ITS C-TERMINAL FLANKING PEPTIDE IN HUMAN RENAL TISSUE

被引:18
作者
GROUZMANN, E
ALVAREZBOLADO, G
MEYER, C
OSTERHELD, MC
BURNIER, M
BRUNNER, HR
WAEBER, B
机构
[1] UNIV LAUSANNE HOSP,DIV HYPERTENS,CH-1010 LAUSANNE,SWITZERLAND
[2] UNIV LAUSANNE HOSP,CARDIOVASC RES GRP,CH-1010 LAUSANNE,SWITZERLAND
[3] INST BIOL ANIM,LAUSANNE,SWITZERLAND
[4] INST PATHOL,LAUSANNE,SWITZERLAND
关键词
NPY; CPON; IMMUNOHISTOCHEMISTRY; HUMAN KIDNEY; ELISA; MONOCLONAL ANTIBODY;
D O I
10.1016/0196-9781(94)90112-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We produced and characterized three anti-C-flanking peptides of neuropeptide Y (CPON) manoclonal antibodies. The K-a for these antibodies ranged from 0.4 to 0.8 X 10(8) l/mol with an IC50 for CPON(1-30) at about 20 nM as determined by ELISA. Ail these antibodies are IgG I and recognize the 16-30 part of CPON. These antibodies and a specific anti-NPY monoclonal antibody were used to study the localization of CPON and NPY in the human kidney. The avidin-biotin technique was employed. NPY and CPON immunoreactivities were present in large amount in the renal tubules of the human kidney but not in the glomeruli. No labeling was found within the renal arterioles and veins, but some immunoreactivity was evidenced in the perivascular area. Because no specific receptor for CPON has been described to date, the presence of this peptide in the tubules may be due to a tubular reabsorption or perhaps to a local synthesis of pro-NPY.
引用
收藏
页码:1377 / 1382
页数:6
相关论文
共 20 条
[1]   NEUROPEPTIDE-Y AND ITS FLANKING PEPTIDE IN HUMAN ENDOCRINE TUMORS AND PLASMA [J].
ALLEN, JM ;
YEATS, JC ;
CAUSON, R ;
BROWN, MJ ;
BLOOM, SR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (06) :1199-1204
[2]   NEUROPEPTIDE-Y - A NOVEL RENAL PEPTIDE WITH VASOCONSTRICTOR AND NATRIURETIC ACTIVITY [J].
ALLEN, JM ;
RAINE, AEG ;
LEDINGHAM, JGG ;
BLOOM, SR .
CLINICAL SCIENCE, 1985, 68 (04) :373-377
[3]   PRESENCE OF THE PREDICTED C-FLANKING PEPTIDE OF NEUROPEPTIDE-Y (CPON) IN TISSUE-EXTRACTS [J].
ALLEN, JM ;
POLAK, JM ;
BLOOM, SR .
NEUROPEPTIDES, 1985, 6 (02) :95-100
[4]  
BALLESTA J, 1984, HISTOCHEMISTRY, V80, P483, DOI 10.1007/BF00495438
[5]   MECHANISM OF NEUROPEPTIDE Y INHIBITION OF VASOPRESSIN ACTION IN RAT CORTICAL COLLECTING TUBULE [J].
DILLINGHAM, MA ;
ANDERSON, RJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (03) :F408-F413
[6]   NEUROPEPTIDE-Y - CEREBROVASCULAR INNERVATION AND VASOMOTOR EFFECTS IN THE CAT [J].
EDVINSSON, L ;
EMSON, P ;
MCCULLOCH, J ;
TATEMOTO, K ;
UDDMAN, R .
NEUROSCIENCE LETTERS, 1983, 43 (01) :79-84
[7]   NEUROPEPTIDE-Y INHIBITS CAMP ACCUMULATION IN RENAL PROXIMAL CONVOLUTED TUBULES [J].
EDWARDS, RM .
REGULATORY PEPTIDES, 1990, 30 (03) :201-206
[8]   ISOLATION OF PURE IGG1, IGG2A AND IGG2B IMMUNOGLOBULINS FROM MOUSE SERUM USING PROTEIN A-SEPHAROSE [J].
EY, PL ;
PROWSE, SJ ;
JENKIN, CR .
IMMUNOCHEMISTRY, 1978, 15 (07) :429-436
[9]   MEASUREMENTS OF THE TRUE AFFINITY CONSTANT IN SOLUTION OF ANTIGEN-ANTIBODY COMPLEXES BY ENZYME-LINKED IMMUNOSORBENT-ASSAY [J].
FRIGUET, B ;
CHAFFOTTE, AF ;
DJAVADIOHANIANCE, L ;
GOLDBERG, ME .
JOURNAL OF IMMUNOLOGICAL METHODS, 1985, 77 (02) :305-319
[10]   PLASMA NEUROPEPTIDE-Y CONCENTRATIONS IN PATIENTS WITH NEURO-ENDOCRINE TUMORS [J].
GROUZMANN, E ;
COMOY, E ;
BOHUON, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (04) :808-813